| abstract |
The invention relates to an oil-in-water nanoemulsion for MRI, including: an aqueous phase; a fluorinated phase including at least one fluorinated oil; a surfactant at the interface between the aqueous and fluorinated phases, the surfactant including: at least one amphiphilic targeting ligand, at least one amphiphilic lipid, and at least one diblock or triblock fluorophilic compound, as well as to the use thereof as a contrast agent. |